Nomad Foods Ltd

NOMD

Nomad Foods Limited, together with its subsidiaries, manufactures, markets, and distributes a range of frozen food products in the United Kingdom and internationally. The company offers frozen fish products, including fish fingers, coated fish, and natural fish; ready-to-cook vegetable products, such as peas and spinach; and frozen poultry and meat products, comprising nuggets, grills, and burgers.

About the company

Country: United KingdomPrice: $11.92Market Cap: $1.7B

Investment snapshot

47%positive consensus

Scored 1d ago

Positive

BUY / PASS

Neutral / negative

5 / 4

NEUTRAL / FAIL

Median fair value

$20.18

+69.3% vs price

Models with upside

8 / 17

Positive margin of safety

Strongest signal

9 of 10 pass — Lynch objects

Key risk

Split decision: 6 PASS · 5 NEUTRAL · 4 FAIL · 1 BUY

Framework analysis

Verdict	Meaning
BUY	Positive purchase signal: the framework's buy requirements are met.
PASS	The company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRAL	Neither a positive nor negative conclusion. It does not mean to hold an existing position.
FAIL	The company does not clear the framework's requirements.
Ranked	Ranked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

Metric	Graham Defensive Value	Buffett Quality Compounder	Lynch GARP	Greenblatt Magic Formula	Piotroski F-Score	Dreman Contrarian Value	Munger Quality Focus	Pabrai Dhandho Framework	Akre Three-Legged Stool	Marks Risk-Aware Value	Ackman Activist Value	Templeton Global Bargain Hunter	Sleep Scale Economies Shared	Asness Systematic Factors	Neff Low-P/E Total Return	Schloss Asset-Value Discipline	O'Shaughnessy Systematic Factor Composite
Verdict	PASS	FAIL	FAIL	BUY · Rank #280 (Top 9%)	PASS	PASS	PASS	NEUTRAL	FAIL	BUY	PASS	PASS	NEUTRAL	FAIL	NEUTRAL	NEUTRAL	NEUTRAL
Score
Analysis	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…	Checking access…
Intrinsic Value (annual)			N/A		N/A								N/A	N/A	N/A	N/A	N/A
Margin of Safety	+46.5%	-13.2%	N/A	+44.5%	N/A	+36.9%	+56.2%	-58.1%	+51.1%	+27.4%	+72.1%	+22.1%	N/A	N/A	N/A	N/A	N/A
Financial Basis	Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Qualitative assessment · Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 · Market data at 2026-11-01 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 · Qualitative assessment Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 Latest source filing: 2026-02-26 Score computed: 2026-11-14	Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 Latest source filing: 2026-02-26 Score computed: 2026-11-14

Where It Passes

Cash Flow90% pass✓ 11✗ 1▾
9 of 10 pass — Lynch objects
Free Cash Flow Proxy$196.9M
✓BuffettPositive and growing
FCF Positive and Growing$296.3M
✗LynchPositive and growing
Operating Cash Flow$388.5M
✓PiotroskiCFO > 0
(CFO / Total Assets) vs ROACFO/Assets=5.22%, ROA=2.16%
✓PiotroskiCFO/Assets > ROA
Price / (CFO / Shares)4.4x
✓Dreman< 8x
P/E or FCF YieldP/E=11.2x, FCF Yield=17.8%
✓PabraiP/E < 15 or FCF Yield > 10%
FCF Positive10/11 years FCF positive
✓MarksPositive FCF in majority of recent years
(OCF - CapEx) / Market Cap17.5%
✓Ackman>= 4%
Price / FCF per Share5.7x
✓Ackman<= 25
Positive Operating Cash Flow frequency10/11 years positive
✓SleepPositive OCF in >= 70% of available years
Operating Cash Flow - Capital Expenditures$296.3M
✓Neff> $0 (app proxy for a strong fundamental case)
(Operating cash flow - capex) / market capitalization+17.78%; #335/4519 (top 7.4%)
✓OshaughnessyTop 10% of eligible cross-section
Valuation models80% pass✓ 8✗ 2▾
Models split on NOMD at $11.92 — fair values range $7.54–$42.77
Graham fair value$22.26
✓Graham+46.5% margin vs $11.92
Buffett fair value$10.53
✗Buffett-13.2% margin vs $11.92
Greenblatt fair value$21.48
✓Greenblatt+44.5% margin vs $11.92
Dreman fair value$18.88
✓Dreman+36.9% margin vs $11.92
Munger fair value$27.19
✓Munger+56.2% margin vs $11.92
Pabrai fair value$7.54
✗Pabrai-58.1% margin vs $11.92
Akre fair value$24.40
✓Akre+51.1% margin vs $11.92
Marks fair value$16.42
✓Marks+27.4% margin vs $11.92
Ackman fair value$42.77
✓Ackman+72.1% margin vs $11.92
Templeton fair value$15.30
✓Templeton+22.1% margin vs $11.92
Verdicts67% pass✓ 8✗ 4▾
Split decision: 6 PASS · 5 NEUTRAL · 4 FAIL · 1 BUY
Overall verdict
✓GrahamPASS (4/9)✗BuffettFAIL (2/9)✗LynchFAIL (0/7)✓GreenblattRank #280✓PiotroskiPASS (F-Score 4)✓DremanPASS (6/11)✓MungerPASS (2/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (1/6)✓MarksBUY (4/5)✓AckmanPASS (5/9)✓TempletonPASS (4/8)•SleepNEUTRAL (4/6)✗AsnessFAIL (Rank #763/2370 (Top 32.2%))•NeffNEUTRAL (4/6)•SchlossNEUTRAL (4/7)•OshaughnessyNEUTRAL (Not ranked)
Valuation54% pass✓ 19✗ 9▾
7 of 13 pass — Lynch, Greenblatt, Templeton +3 more object
Net income / market capitalization+9.63%; #704/6340 (top 11.1%)
✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Price / 3-yr avg EPS9.5x
✓Graham<= 15x
Price-to-Book Ratio0.6x
✓Graham<= 1.5x
P/E x P/B5.50
✓Graham<= 22.5
Basic earnings-growth PEG (dividends excluded)P/E 11.2x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
EBIT / Enterprise Value8.8%
✗Greenblatt> 10%
Earnings Yield + ROC AssessmentEY=8.8%, ROC=50.9%
✗GreenblattBoth EY > 10% and ROC > 25%
Price / EPS11.2x
✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
Price / (CFO / Shares)4.4x
✓Dreman< 8x
Price / Book Value per Share0.6x
✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)
Valuation ReasonablenessP/E=11.2x, OE Yield=11.6%
✓MungerP/E < 25 or Owner Earnings Yield > 5%
P/E or FCF YieldP/E=11.2x, FCF Yield=17.8%
✓PabraiP/E < 15 or FCF Yield > 10%
P/B or P/E vs. Historical AverageP/E=11.2x, P/B=0.6x
✓MarksP/E < 15 or P/B < 2.0
Discount to Intrinsic Value36.9% (IV=$18.88 vs Price=$11.92)
✓Marks>= 20% below intrinsic value
Price / FCF per Share5.7x
✓Ackman<= 25
Price vs. Trailing Low124% of trailing low ($9.61)
✗Templeton<= 120% of trailing low (certified split-adjusted live window)
Positive book equity / market capitalization+1.7598; #766/6449 (top 11.9%)
✓AsnessTop 30% of eligible cross-section
Price / Diluted EPS11.2x
✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
(EPS CAGR % + Dividend Yield %) / P/E0.09
✗Neff> 0.7 (Neff's published traditional edge)
Price / Tangible Book Value per ShareN/A (non-positive TBVPS)
✗SchlossP/TBV <= 1.00x (app cutoff)
Book Value per Share Change+35.6%
✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
Revenue / market capitalization+2.1373; #1027/5247 (top 19.6%)
✗OshaughnessyTop 10% of eligible cross-section
(Operating cash flow - capex) / market capitalization+17.78%; #335/4519 (top 7.4%)
✓OshaughnessyTop 10% of eligible cross-section
Trailing six-month price return through the evaluation date+20.89%; #1300/6202 (top 21.0%)
✗OshaughnessyTop 10% of eligible cross-section

Where It Falls Short

Growth13% pass✓ 4✗ 9▾
7 of 8 flag NOMD's growth — Graham, Lynch, Dreman +4 more
EPS Growth (3-yr avg, 10-yr window)
✗Graham>= 33% growth
Basic earnings-growth PEG (dividends excluded)P/E 11.2x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR-5.3%
✗Lynch15-30% (Fast Grower); > 0% to pass
Inventory Growth vs Revenue GrowthInv: 12.7% vs Rev: 10.4%
✗LynchInventory growth < Revenue growth
EPS Growth Direction
✗DremanPositive over recent years
EPS CAGR19.0% CAGR over 9 years
✓Dreman> 5% annualized
Positive Net Income Frequency10/11 years positive
✓MarksPositive net income in >= 7 of last 10 years
3yr Median Revenue Growth7.5%
✓Ackman>= 5%
Positive EPS Growth Frequency2/5 years with positive EPS growth
✗AckmanPositive EPS growth in >= 3 of last 5 years
5-Year EPS CAGR-5.3% CAGR over 5 years
✗Templeton> 0% (5-year EPS CAGR)
Revenue growth vs. gross and operating margin trendgross margin 28.2% -> 27.1%, operating margin 11.2% -> 10.7%
✓SleepRevenue rising; gross margin flat or falling; operating margin holding
5-year Revenue CAGR2.9%
✗SleepCAGR > 7%
3-5 Year Diluted EPS CAGR-5.3% over 5 years
✗Neff7%-20% annualized
Efficiency13% pass✓ 1✗ 10▾
7 of 8 flag NOMD's efficiency — Graham, Buffett, Piotroski +4 more
Current Ratio1.07
✗Graham>= 2.0
ROIC (3-5 yr avg)6.1%
✗Buffett> 10%
ROIC - WACC-3.9%
✗BuffettPositive (WACC = 10%)
EBIT / (NWC + Net Fixed Assets)50.9%
✓Greenblatt> 25%
Current Ratio Change YoY1.10 -> 1.07
✗PiotroskiIncreased YoY
Revenue / Total Assets Change YoY0.48x -> 0.48x
✗PiotroskiImproved YoY
Current Assets / Current Liabilities1.07
✗Dreman> 1.5
Return on Invested Capital5.4%
✗Munger> 15%
ROIC (high and growing)FY2023: ROIC=5.7%; FY2024: ROIC=6.3%; FY2025: ROIC=5.4%
✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
Reinvestment Rate x ROIC1.8% (RR=33% x ROIC=5.4%)
✗AkreReinvestment Rate * ROIC > 10%
ROIC (5-year)0/5 years above 12% (latest 5.4%)
✗SleepROIC > 12% in a majority of years
Debt & Leverage17% pass✓ 3✗ 12▾
10 of 12 flag NOMD's debt & leverage — Graham, Buffett, Lynch +7 more
Total Debt / Shareholders' Equity0.92
✗Dreman< 0.8✓Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✓SchlossD/E < 1.00x
LT Debt vs Net Current AssetsLT Debt $2.7B vs NCA $92.7M
✗GrahamLT Debt <= Net Current Assets
Debt/Equity & Interest CoverageD/E: 0.92, IC: 1.7x
✗BuffettD/E < 0.5 AND Interest Coverage > 5x
Total Debt / Equity0.92
✗Lynch< 0.33
Cash - Long-term Debt
✗LynchPositive preferred
LT Debt / Total Assets Change33.45% -> 35.65%
✗PiotroskiDecreased YoY
Current Assets / Current Liabilities1.07
✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
Debt Levels0.92
✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
Interest Coverage & Debt/EBITDAIC=1.7x, D/EBITDA=5.3x
✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
Total Debt / Shareholders Equity0.92
✓Ackman<= 1.0
Negative debt-to-equity (higher means less debt)-0.9177; #3124/4210 (top 74.2%)
✗AsnessTop 30% of eligible cross-section
Profitability25% pass✓ 11✗ 24▾
12 of 16 flag NOMD's profitability — Graham, Buffett, Lynch +9 more
Net income / market capitalization+9.63%; #704/6340 (top 11.1%)
✓AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
Positive EPS (10 years)10/13 years positive
✗GrahamPositive EPS every year for 10 years
EPS Growth (3-yr avg, 10-yr window)
✗Graham>= 33% growth
Net Income Positive (10+ years)10/13 years positive
✗BuffettPositive every year for 10+ years
ROE (up to 5-year arithmetic mean)7.8%
✗Buffett> 15% arithmetic mean (app rule)
Operating Margin (10-yr trend)10.7% (latest)
✓BuffettStable or rising over 10 years
Free Cash Flow Proxy$196.9M
✓BuffettPositive and growing
Earnings Variance (10-yr CoV)
✗BuffettCoV < 0.3
Retained Earnings Effectiveness
✗Buffett$1 retained -> > $1 market value created
Basic earnings-growth PEG (dividends excluded)P/E 11.2x (growth N/A)
✗Lynch< 1.0 (ideally < 0.5)
3-5 Year EPS CAGR-5.3%
✗Lynch15-30% (Fast Grower); > 0% to pass
ROE5.5%
✗Lynch> 15%
EBIT / Enterprise Value8.8%
✗Greenblatt> 10%
Earnings Yield + ROC AssessmentEY=8.8%, ROC=50.9%
✗GreenblattBoth EY > 10% and ROC > 25%
Net Income / Total Assets2.16%
✓PiotroskiROA > 0
ROA Change YoY3.53% -> 2.16% (delta: -1.37%)
✗PiotroskiCurrent ROA > Prior ROA
(CFO / Total Assets) vs ROACFO/Assets=5.22%, ROA=2.16%
✓PiotroskiCFO/Assets > ROA
Gross Margin Change YoY29.6% -> 27.1%
✗PiotroskiImproved YoY
Pre-Tax Income / Revenue4.8%
✗Dreman>= 8%
Net Income / Shareholders' Equity5.5%
✗Dreman> 12%
Margin of SafetyP/E=11.2x, P/B=0.6x
✓PabraiP/B < 1.5 or P/E < 15
Return on Equity7.1% (3-yr avg)
✗AkreROE > 20% (3-year avg)
Discount to Intrinsic Value36.9% (IV=$18.88 vs Price=$11.92)
✓Marks>= 20% below intrinsic value
Positive Net Income Frequency10/11 years positive
✓MarksPositive net income in >= 7 of last 10 years
Operating Income / Revenue10.7%
✗Ackman>= 15%
Net Income / Shareholders Equity5.5%
✗Ackman>= 15%
5-Year EPS CAGR-5.3% CAGR over 5 years
✗Templeton> 0% (5-year EPS CAGR)
Operating Margin Trend11.2% (2023) -> 10.7% (2025)
✗TempletonNon-negative operating-margin trend over 3 years
Revenue growth vs. gross and operating margin trendgross margin 28.2% -> 27.1%, operating margin 11.2% -> 10.7%
✓SleepRevenue rising; gross margin flat or falling; operating margin holding
Gross profit / total assets+12.99%; #2568/3702 (top 69.4%)
✗AsnessTop 30% of eligible cross-section
Net income / positive book equity+5.48%; #2405/5226 (top 46.0%)
✗AsnessTop 30% of eligible cross-section
Negative 5-year standard deviation of ROA-0.0060; #556/5884 (top 9.4%)
✓AsnessTop 30% of eligible cross-section
3-5 Year Diluted EPS CAGR-5.3% over 5 years
✗Neff7%-20% annualized
Positive Diluted-EPS Years10/10 years positive
✓Schloss>= 70% positive over 5-10 observed years (app rule)

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Food Products

Size: Small Cap($1.7B)

Revenue: $3.6B+10.4% YoY

Net Income: $160.6M-32.0% YoY

Financial Snapshot

Operating Margin10.7%

Return on Equity5.5%

Debt / Equity0.92

Current Ratio1.07

EPS (Diluted)$1.07−26.6% 1y

Buybacks (1y)$229.8M

Buybacks (2y)$353.3M

Shares Retired8.8% / 12.7% 2y

Similar Companies

MDLZMondelez International, Inc.

$85.5B

ADMArcher-Daniels-Midland Co

Shareholder Return

Fiscal 2025

Retired 8.8% of shares last year, 12.7% over two.

Buybacks: $229.8M
Dividends: $107.3M

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY22

32.0% = 29.9% + 1.6%

FY23

−18.0% = −19.9% + 2.4%

FY24

16.5% = 10.8% + 5.1%

FY25

−26.6% = −32.0% + 8.0%

Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

Metric	FY 2025 Sources 20-F · 2026-02-26	FY 2024 Sources 20-F · 2025-03-03	FY 2023 Sources 20-F · 2024-02-29	FY 2022 Sources 20-F · 2023-02-23	FY 2021 Sources 20-F · 2022-03-03
Market Cap	$1.7Bcurrent	$2.6Best.	$2.7Best.	$2.8Best.	$4.1Best.
Revenue	$3.6B↑10%	$3.2B↓4%	$3.4B↑8%	$3.1B↑6%	$3.0B
Operating Income	$382.3M↓5%	$402.7M↑7%	$376.8M↓6%	$400.2M↑3%	$388.1M
Net Income	$160.6M↓32%	$236.3M↑11%	$213.3M↓20%	$266.3M↑30%	$205.0M
EPS (Diluted)	$1.07↓27%	$1.46↑16%	$1.25↓18%	$1.52↑32%	$1.16
Gross Margin	27.1%↓8%	29.6%↑5%	28.2%↑2%	27.7%↓3%	28.6%
Operating Margin	10.7%↓14%	12.5%↑12%	11.2%↓12%	12.8%↓3%	13.1%
ROE	5.5%↓36%	8.5%↑15%	7.4%↓22%	9.6%↑22%	7.9%
Total Debt	$2.7B↑19%	$2.3B↓4%	$2.4B↑2%	$2.3B↓9%	$2.5B
Shareholders' Equity	$2.9B↑6%	$2.8B↓3%	$2.9B↑3%	$2.8B↑7%	$2.6B
Current Ratio	1.07↓2%	1.10↓3%	1.13↓4%	1.19↑23%	0.96
Debt / Equity	0.92↑12%	0.82↓1%	0.82↓1%	0.83↓14%	0.97
Operating Cash Flow	$388.5M↓14%	$453.1M↓5%	$476.8M↑47%	$323.9M↓7%	$346.9M
Free Cash Flow	$296.3M↓20%	$369.5M↓4%	$385.6M↑61%	$239.5M↓7%	$257.2M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Food Products

NOMD vs Peers — Financial Grading

Revenue$3.6BBottom 25%

Net Income$160.6MBottom 25%

ROE5.5%Median

D/E0.92Median

Op. Margin10.7%Top 25%

Curr. Ratio1.07Median

Company	Market Cap	Price	Revenue	Net Income	ROE	D/E	Op. Margin	Curr. Ratio	Graham	Buffett	Lynch	Greenblatt	Piotroski	Dreman
Mondelez International, Inc.MDLZ	$85.5B	$67.54	$38.5B	$2.5B	9.5%	0.72	9.2%	0.59	2/9	3/9	3/7	0/3	F-Score 6	4/11
Archer-Daniels-Midland CoADM	$34.7B	$72.90	$80.3B	$1.1B	4.7%	0.33	—	1.37	5/9	2/9	1/7	0/3	F-Score 5	5/11
TYSON FOODS, INC.TSN	$20.7B	$58.82	$54.4B	$474.0M	2.6%	0.49	2.0%	1.55	3/9	2/9	0/7	0/3	F-Score 5	3/11
GENERAL MILLS INCGIS	$18.4B	$34.32	$18.4B	$87.6M	-1.2%	1.83	4.8%	0.68	3/9	4/9	0/7	1/3	F-Score 5	2/11
HORMEL FOODS CORP /DE/HRL	$12.2B	$22.09	$12.1B	$478.2M	6.1%	0.36	5.9%	2.47	3/9	3/9	2/7	0/3	F-Score 5	4/11
Lamb Weston Holdings, Inc.LW	$7.7B	$56.06	$6.6B	$290.0M	15.9%	2.01	8.9%	1.42	2/9	4/9	0/7	0/3	F-Score 7	3/11
SMITHFIELD FOODS INCSFD	$7.6B	$19.19	$15.5B	$987.0M	14.5%	0.29	8.3%	2.97	6/9	3/9	3/7	3/3	F-Score 6	8/11
CONAGRA BRANDS INC.CAG	$7.0B	$14.73	$11.3B	$1.9B	-30.1%	1.14	-14.4%	0.90	3/9	0/9	1/7	0/3	F-Score 4	4/11